The Medserve-LUTH Cancer Centre, MLCC, has been named “Most Outstanding Oncology Centre in Nigeria” for the fourth consecutive year.
The award was presented at the 12th Nigerian Healthcare Excellence Award held on 26 June 2026. The latest recognition further strengthens MLCC’s standing as a leading centre for advanced, compassionate and life-saving cancer care in Nigeria and the West African sub-region.
Located within the Lagos University Teaching Hospital, Idi-Araba, Lagos, MLCC is regarded as the largest and best-equipped cancer treatment facility in West Africa. The centre combines cutting-edge technology with clinical expertise to deliver highly specialised, multidisciplinary outpatient care, helping to reduce the need for medical tourism abroad.
The four consecutive awards reflect the centre’s sustained commitment to expanding access to world-class cancer treatment, investing in modern infrastructure, and delivering international-standard care to patients in Nigeria.
Since its establishment, MLCC has continued to transform oncology care in West Africa through a holistic model that integrates radiotherapy, chemotherapy and supportive therapies. This consistent national recognition underscores the impact of its unified, multidisciplinary approach to cancer treatment and survivorship.
Also Read: LUTH begins clinical trial against colorectal cancer
Organised by Global Health Project and Resources in collaboration with the Anadach Group, the event brought together key stakeholders in Nigeria’s healthcare sector. The Minister of State for Health and Social Welfare, Dr Iziaq Adekunle Salako, attended as Special Guest of Honour, while Lagos State Governor, Mr Babajide Olusola Sanwo-Olu, served as Chief Host.
The award was received on behalf of the centre by Dr Muhammed Habeebu, Chief Clinical Coordinator of the Medserve-LUTH Cancer Centre.
The recognition further reinforces LUTH’s position as a leading tertiary healthcare institution committed to excellence in specialised healthcare delivery, research, innovation and patient-centred care. It also highlights the success of the collaboration between LUTH and Medserve in building a centre that has significantly advanced cancer care in Nigeria and across West Africa.
The Chief Medical Director at LUTH, Prof. Wasiu Adeyemo said: “MLCC’s continued success also reflects the Federal Government of Nigeria’s commitment under the Renewed Hope Agenda of President Bola Ahmed Tinubu, to improving access to quality healthcare for Nigerians.”
Crediblenewsng.com
